Breaking News

Symbiosis Begins Commercial Manufacturing at Stirling, UK Facility

Manufactures first 10,000 vial batch to support the development of a cancer immunotherapy in Phase III trials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Symbiosis Stirling

Symbiosis Pharmaceutical Services, a sterile fill finish contract manufacturing organization (CMO), has manufactured its first 10,000 vial batch at the company’s new facility in Stirling, UK.  The project supports the development of a cancer immunotherapy currently in Phase III trials. The production batch of 10,000 vials marks a milestone in the company’s planned expansion of its sterile manufacturing capacity. The FDA-inspected and MHRA-licensed facility supports clients from clinical tr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters